Steven Brooks

Deep Water Point LLC provides consulting services. It offers market intelligence and analysis, business development, capture management and proposal support, strategic account planning and sales support, messaging and requirements alignment with funding initiatives, competitive analysis, channel partner model optimization and general business model advisory services. The company was founded by Howard C. Seeger in 2002 and is headquartered in McLean, VA.

Ablative Solutions, Inc. develops and markets endovascular catheters for the treatment of hypertension. It offers solutions for heart failure, kidney disease, metabolic syndrome, and sleep apnea. The company was founded by Tim A. Fischell and David R. Fischell in 2011 and is headquartered in San Jose, CA.

NDA Partners LLC provides strategy consulting services. It also provides a comprehensive range of services across the product development life cycle for drugs, biologics, biosimilars, vaccines, generics, devices, combination products and diagnostics. The company was founded by Carl C. Peck and Earle Martin and is headquartered in Annapolis, MD.

Global Interconnect, Inc. manufactures electronic cables.

Popper & Co. LLC is a strategy consulting and transaction advisory firm. It serves the medical technology and life sciences industries. The company was founded by Caroline Popper and Kenneth G. Walz on June 1, 2003 and is headquartered in Baltimore, MD.

Cardiocube Corp. develops healthcare system software. The American company was founded by Oscar Kiwic, Chris Grabowski, Rodney Anderson, Tom Jadczyk, Przemek Magaczewski. Oscar Kiwic has been the CEO since incorporation.

Vita Therapeutics, Inc. is a biotechnology company based in Baltimore, MD that develops state-of-the-art cellular therapeutics for the treatment of neuromuscular diseases and cancers. The company uses induced pluripotent stem cell (iPSC) technology to engineer specific cell types designed to replace those that are defective in patients. Vita Therapeutics is progressing its co-leading programs VTA-100 and VTA-300 for the treatment of limb-girdle muscular dystrophy (LGMD) and multiple solid tumors with the goal of filing investigational drug applications with the Food and Drug Administration in 2023. The company is developing these proprietary cellular therapies following a dual development strategy beginning with autologous-derived cells before moving to a universal hypoimmunogenic cell line. Vita Therapeutics was founded in 2019 by Douglas Taylor Falk, M.S. and Peter Andersen, Ph.D. Douglas Taylor Falk has been the CEO since 2019.

MEDA Angels LLC (MEDA Angels) is a venture capital firm founded in 2019 by Elizabeth Cho-Fertikh, Amir Rafii, Mark J. Libassi and Ferdinand Hui. The firm is headquartered in Arlington, Virginia.